Discuss This Drug

belimumab

CHEBI:CHEBI_755445

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
belimumab
listing_expiration_date
20251231
active_ingredient_strength
400 mg/5mL
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Hospira, Inc.
marketing_start_date
20140310
package_marketing_start_date
10-MAR-14
product_ndc
0409-9966
spl_id
59a9bc37-5c8a-45d0-a308-0d97fc303304
active_ingredient_name
BELIMUMAB
package_ndc
0409-9966-01
package_description
192 VIAL in 1 PACKAGE (0409-9966-01) / 5 mL in 1 VIAL (0409-9966-11)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class